Literature DB >> 19592283

The INPHARMA technique for pharmacophore mapping: A theoretical guide to the method.

Julien Orts1, Christian Griesinger, Teresa Carlomagno.   

Abstract

During the process of drug discovery, INPHARMA can be used to derive the structure of receptor/lead compound complexes binding to each other with a K(d) in the microM to mM range. To be successful, the methodology needs adjustment of various parameters that depend on the physical constants of the binding event and on the receptor size. Here we present a thorough theoretical analysis of the INPHARMA interligand NOE effect in dependence of experimental parameters and physical constants. This analysis helps the experimentalist to choose the correct experimental parameters and consequentially to achieve optimal performance of the methodology.

Mesh:

Substances:

Year:  2009        PMID: 19592283     DOI: 10.1016/j.jmr.2009.06.006

Source DB:  PubMed          Journal:  J Magn Reson        ISSN: 1090-7807            Impact factor:   2.229


  5 in total

1.  An NMR strategy for fragment-based ligand screening utilizing a paramagnetic lanthanide probe.

Authors:  Tomohide Saio; Kenji Ogura; Kazumi Shimizu; Masashi Yokochi; Terrence R Burke; Fuyuhiko Inagaki
Journal:  J Biomol NMR       Date:  2011-09-17       Impact factor: 2.835

2.  The description of protein internal motions aids selection of ligand binding poses by the INPHARMA method.

Authors:  Benjamin Stauch; Julien Orts; Teresa Carlomagno
Journal:  J Biomol NMR       Date:  2012-09-22       Impact factor: 2.835

3.  Site specific polarization transfer from a hyperpolarized ligand of dihydrofolate reductase.

Authors:  Yunyi Wang; Mukundan Ragavan; Christian Hilty
Journal:  J Biomol NMR       Date:  2016-05-17       Impact factor: 2.835

4.  Inhibition of CPAP-tubulin interaction prevents proliferation of centrosome-amplified cancer cells.

Authors:  Aruljothi Mariappan; Komal Soni; Kenji Schorpp; Fan Zhao; Amin Minakar; Xiangdong Zheng; Sunit Mandad; Iris Macheleidt; Anand Ramani; Tomáš Kubelka; Maciej Dawidowski; Kristina Golfmann; Arpit Wason; Chunhua Yang; Judith Simons; Hans-Günther Schmalz; Anthony A Hyman; Ritu Aneja; Roland Ullrich; Henning Urlaub; Margarete Odenthal; Reinhardt Büttner; Haitao Li; Michael Sattler; Kamyar Hadian; Jay Gopalakrishnan
Journal:  EMBO J       Date:  2018-12-10       Impact factor: 11.598

5.  Suppression of problematic compound oligomerization by cosolubilization of nondetergent sulfobetaines.

Authors:  Yumiko Mizukoshi; Koh Takeuchi; Misa Arutaki; Takeshi Takizawa; Hiroyuki Hanzawa; Hideo Takahashi; Ichio Shimada
Journal:  ChemMedChem       Date:  2015-03-11       Impact factor: 3.466

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.